BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 34611981)

  • 1. Clinical manifestations of patients with GDF2 mutations associated with hereditary hemorrhagic telangiectasia type 5.
    Farhan A; Yuan F; Partan E; Weiss CR
    Am J Med Genet A; 2022 Jan; 188(1):199-209. PubMed ID: 34611981
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification and validation of a novel pathogenic variant in GDF2 (BMP9) responsible for hereditary hemorrhagic telangiectasia and pulmonary arteriovenous malformations.
    Balachandar S; Graves TJ; Shimonty A; Kerr K; Kilner J; Xiao S; Slade R; Sroya M; Alikian M; Curetean E; Thomas E; McConnell VPM; McKee S; Boardman-Pretty F; Devereau A; Fowler TA; Caulfield MJ; Alton EW; Ferguson T; Redhead J; McKnight AJ; Thomas GA; ; Aldred MA; Shovlin CL
    Am J Med Genet A; 2022 Mar; 188(3):959-964. PubMed ID: 34904380
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mutational and phenotypic characterization of hereditary hemorrhagic telangiectasia.
    Shovlin CL; Simeoni I; Downes K; Frazer ZC; Megy K; Bernabeu-Herrero ME; Shurr A; Brimley J; Patel D; Kell L; Stephens J; Turbin IG; Aldred MA; Penkett CJ; Ouwehand WH; Jovine L; Turro E
    Blood; 2020 Oct; 136(17):1907-1918. PubMed ID: 32573726
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mutational and clinical spectrum of Japanese patients with hereditary hemorrhagic telangiectasia.
    Kitayama K; Ishiguro T; Komiyama M; Morisaki T; Morisaki H; Minase G; Hamanaka K; Miyatake S; Matsumoto N; Kato M; Takahashi T; Yorifuji T
    BMC Med Genomics; 2021 Dec; 14(1):288. PubMed ID: 34872578
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mutations in the ENG, ACVRL1, and SMAD4 genes and clinical manifestations of hereditary haemorrhagic telangiectasia: experience from the Center for Osler's Disease, Uppsala University Hospital.
    Karlsson T; Cherif H
    Ups J Med Sci; 2018 Sep; 123(3):153-157. PubMed ID: 30251589
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical and molecular characterization of patients with hereditary hemorrhagic telangiectasia: Experience from an HHT Center of Excellence.
    Latif MA; Sobreira NLD; Guthrie KS; Motaghi M; Robinson GM; Shafaat O; Gong AJ; Weiss CR
    Am J Med Genet A; 2021 Jul; 185(7):1981-1990. PubMed ID: 33768677
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mutation affecting the proximal promoter of Endoglin as the origin of hereditary hemorrhagic telangiectasia type 1.
    Albiñana V; Zafra MP; Colau J; Zarrabeitia R; Recio-Poveda L; Olavarrieta L; Pérez-Pérez J; Botella LM
    BMC Med Genet; 2017 Feb; 18(1):20. PubMed ID: 28231770
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A
    Ma L; Peng X; Gong Q
    J Int Med Res; 2023 Mar; 51(3):3000605231159545. PubMed ID: 36891821
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New genetic drivers in hemorrhagic hereditary telangiectasia.
    Cerdà P; Castillo SD; Aguilera C; Iriarte A; Rocamora JL; Larrinaga AM; Viñals F; Graupera M; Riera-Mestre A
    Eur J Intern Med; 2024 Jan; 119():99-108. PubMed ID: 37689549
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phenotype of CM-AVM2 caused by variants in EPHB4: how much overlap with hereditary hemorrhagic telangiectasia (HHT)?
    Wooderchak-Donahue WL; Akay G; Whitehead K; Briggs E; Stevenson DA; O'Fallon B; Velinder M; Farrell A; Shen W; Bedoukian E; Skrabann CM; Antaya RJ; Henderson K; Pollak J; Treat J; Day R; Jacher JE; Hannibal M; Bontempo K; Marth G; Bayrak-Toydemir P; McDonald J
    Genet Med; 2019 Sep; 21(9):2007-2014. PubMed ID: 30760892
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The ACVRL1 c.314-35A>G polymorphism is associated with organ vascular malformations in hereditary hemorrhagic telangiectasia patients with ENG mutations, but not in patients with ACVRL1 mutations.
    Pawlikowska L; Nelson J; Guo DE; McCulloch CE; Lawton MT; Young WL; Kim H; Faughnan ME;
    Am J Med Genet A; 2015 Jun; 167(6):1262-7. PubMed ID: 25847705
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Genetic diagnostics of hereditary hemorrhagic telangiectasia (Osler-Weber-Rendu disease)].
    Major T; Gindele R; Szabó Z; Jóni N; Kis Z; Bora L; Bárdossy P; Rácz T; Karosi T; Bereczky Z
    Orv Hetil; 2019 May; 160(18):710-719. PubMed ID: 31030535
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Variant analysis in Chinese families with hereditary hemorrhagic telangiectasia.
    Zhao Y; Zhang Y; Wang X; Zhang L
    Mol Genet Genomic Med; 2019 Sep; 7(9):e893. PubMed ID: 31400083
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of a Novel ACVRL1 Gene Mutation (c.100T>A, p.Cys34Ser) in a Japanese Patient with Possible Hereditary Hemorrhagic Telangiectasia (Osler-Weber-Rendu Disease).
    Umemura H; Miura K; Naruse H; Hatta Y; Takei M; Nakayama T
    Acta Med Okayama; 2020 Apr; 74(2):165-169. PubMed ID: 32341592
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sequence variations of ACVRL1 play a critical role in hepatic vascular malformations in hereditary hemorrhagic telangiectasia.
    Giraud S; Bardel C; Dupuis-Girod S; Carette MF; Gilbert-Dussardier B; Riviere S; Saurin JC; Eyries M; Patri S; Decullier E; Calender A; Lesca G
    Orphanet J Rare Dis; 2020 Sep; 15(1):254. PubMed ID: 32962750
    [TBL] [Abstract][Full Text] [Related]  

  • 16. BMP9 mutations cause a vascular-anomaly syndrome with phenotypic overlap with hereditary hemorrhagic telangiectasia.
    Wooderchak-Donahue WL; McDonald J; O'Fallon B; Upton PD; Li W; Roman BL; Young S; Plant P; Fülöp GT; Langa C; Morrell NW; Botella LM; Bernabeu C; Stevenson DA; Runo JR; Bayrak-Toydemir P
    Am J Hum Genet; 2013 Sep; 93(3):530-7. PubMed ID: 23972370
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mutation analysis in Norwegian families with hereditary hemorrhagic telangiectasia: founder mutations in ACVRL1.
    Heimdal K; Dalhus B; Rødningen OK; Kroken M; Eiklid K; Dheyauldeen S; Røysland T; Andersen R; Kulseth MA
    Clin Genet; 2016 Feb; 89(2):182-6. PubMed ID: 25970827
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Curaçao diagnostic criteria for hereditary hemorrhagic telangiectasia is highly predictive of a pathogenic variant in ENG or ACVRL1 (HHT1 and HHT2).
    McDonald J; Bayrak-Toydemir P; DeMille D; Wooderchak-Donahue W; Whitehead K
    Genet Med; 2020 Jul; 22(7):1201-1205. PubMed ID: 32300199
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The clinical and genetic features of hereditary haemorrhagic telangiectasia (HHT) in central South Africa-three novel pathogenic variants.
    Mutize TT; Seedat RY; Ploos van Amstel JK; Mager JJ; Brown SC; Gebremariam F; Coetzee MJ
    Mol Biol Rep; 2020 Dec; 47(12):9967-9972. PubMed ID: 33201366
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Non-invasive CT screening for pulmonary arteriovenous malformations in children with confirmed hereditary hemorrhagic telangiectasia: Results from two pediatric centers.
    Soysal N; Eyries M; Verlhac S; Escabasse V; Remus N; Tamalet A; Rioux JY; Franchi-Abella S; Vasile M; Robert S; Delestrain C; Hau I; Ducou-Le Pointe H; Soubrier F; Carette MF; Epaud R
    Pediatr Pulmonol; 2017 May; 52(5):642-649. PubMed ID: 28165669
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.